LUMRYZ is only currently approved for the treatment of cataplexy or EDS in patients seven years of age and older with narcolepsy, and Avadel does not market, promote or offer patient support services ...
Following closing, combined company plans to progress Yarrow’s lead program, YB-101, a potentially first-in-class anti-thyroid-stimulating ...
Combined company expects to site and commence construction of the first utility-scale fusion power plant in 2026 ...
Disciplined $180 to $190 million development capital budget retains flexibility and targets quick payback opportunities ...
Sometimes the caller says they are from Spectrum Cable or DirecTV. But more often than not, they say they are from “your ...
Lower abandonment rates, shorter wait times and increased appointment scheduling are just three areas where artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback